Tuesday, October 27, 2020 10:26:49 PM
https://www.gilead.com/news-and-press/press-room/press-releases/2020/10/gilead-sciences-completes-acquisition-of-immunomedics-inc
Forget Covid 19 even though Gilead also makes the only drug approved by the FDA to shorten its span and help your immune system fight it to where it doesn’t kill you! Oh yeah and how about this to add to them financials coming out in less than 2 days...
https://www.google.com/amp/s/mobile.reuters.com/article/amp/idUSKBN26Y25K
-GILD
If I am posting on a company’s message board, I more than likely have a position with said company. Everything I post is in my opinion. Go Seahawks!
Recent GILD News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/15/2024 09:12:38 PM
- Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis • Business Wire • 11/15/2024 04:00:00 PM
- Gilead Prices $3.5 Billion of Senior Unsecured Notes • Business Wire • 11/14/2024 01:24:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 11/13/2024 10:13:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/13/2024 02:02:39 PM
- Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow • Business Wire • 11/13/2024 11:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 01:36:10 PM
- Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline • Business Wire • 11/12/2024 10:30:00 AM
- Gilead Sciences to Present at Upcoming Investor Engagements • Business Wire • 11/08/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2024 09:38:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2024 09:32:29 PM
- Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic • Business Wire • 11/07/2024 01:30:00 PM
- Qualcomm Exceeds Expectations, Rises 8%; Wolfspeed Drops 25% on Negative Margin; Lyft and AppLovin Surge Over 20% • IH Market News • 11/07/2024 11:16:12 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2024 09:19:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:09:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2024 09:07:14 PM
- Gilead Sciences Announces Third Quarter 2024 Financial Results • Business Wire • 11/06/2024 09:02:00 PM
- Kite to Highlight Industry-Leading CAR T-Cell Therapy Portfolio at ASH 2024, Including Positive Survival Outcomes in Both Clinical Trials and the Real-World • Business Wire • 11/05/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2024 07:09:29 PM
- Gilead to Present Latest Research Across Key Liver Disease Indication at the American Association for the Study of Liver Disease (AASLD) Meeting 2024 • Business Wire • 10/22/2024 01:00:00 PM
- Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48 • Business Wire • 10/19/2024 09:09:00 PM
- Gilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 • Business Wire • 10/09/2024 08:05:00 PM
- Gilead to Present Late-Breaking Data Highlighting Antiviral Portfolio, Innovative Research Pipeline and HIV Leadership at IDWeek 2024 • Business Wire • 10/09/2024 12:30:00 PM
- Gilead Presents Additional Efficacy, Safety and Demographic Data From PURPOSE 2 Trial at 5th HIV Research for Prevention Conference • Business Wire • 10/07/2024 03:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:58:23 PM
FEATURED Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors • Nov 19, 2024 8:45 AM
FEATURED Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits • Nov 19, 2024 8:34 AM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary • CBDL • Nov 19, 2024 8:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM